Lv43
580 积分 2023-02-08 加入
Trastuzumab deruxtecan in patients with solid tumours harbouring specific activating HER2 mutations (DESTINY-PanTumor01): an international, phase 2 study
4小时前
待确认
Trastuzumab deruxtecan in patients with HER2-positive advanced colorectal cancer (DESTINY-CRC02): primary results from a multicentre, randomised, phase 2 trial
22小时前
已完结
Trastuzumab deruxtecan in patients with metastatic non-small-cell lung cancer (DESTINY-Lung01): primary results of the HER2-overexpressing cohorts from a single-arm, phase 2 trial
22小时前
已完结
Congenital disorders of estrogen biosynthesis and action
15天前
已完结
Elinzanetant for the Treatment of Vasomotor Symptoms Associated With Menopause
23天前
已完结
Efficacy and safety of fezolinetant and elinzanetant for vasomotor symptoms in postmenopausal women: A systematic review and meta-analysis
24天前
已完结
Management of Postmenopausal Osteoporosis
30天前
已完结
In Vitro ADME Profiling of PROTACs: Successes, Challenges, and Lessons Learned from Analysis of Clinical PROTACs from a Diverse Physicochemical Space
1个月前
已完结
STEAP proteins: Roles in disease biology and potential for therapeutic intervention
1个月前
已完结
皖公网安备34019202002308
